COM:PERSPECTIVETHERAPEUTICS
Perspective Therapeutics
- Stock
Last Close
6.17
21/11 21:00
Market Cap
202.76M
Beta: -
Volume Today
12.57M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Jun '14 | Jun '15 | Jun '16 | Jun '17 | Jun '18 | Jun '19 | Jun '20 | Jun '21 | Jun '22 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 382.65K - | 381.85K 0.21% | 369.18K 3.32% | 328.70K 10.96% | 419.50K 27.62% | 523K 24.67% | 587.50K 12.33% | 812.50K 38.30% | 1.19M 46.22% | 1.40M 18.06% | |
average payables | 503.71K - | 536.55K 6.52% | 554.42K 3.33% | 620.29K 11.88% | 1.01M 62.91% | 1.04M 2.62% | 668.50K 35.54% | 692K 3.52% | 848K 22.54% | 1.25M 47.82% | |
average receivables | 950.71K - | 1.02M 7.01% | 836.82K 17.75% | 665.49K 20.47% | 959K 44.10% | 1.17M 22.31% | 1.60M 36.32% | 2.03M 26.86% | 1.81M 10.75% | 1.49M 17.95% | |
book value per share | 0.56 - | 0.38 32.54% | 0.30 21.27% | 0.19 35.36% | 0.09 52.68% | 0.11 25.62% | 0.08 26.10% | 0.65 666.76% | 0.43 33.52% | 0.38 10.90% | |
capex per share | -0.00 - | -0.00 219.69% | -0.01 224.35% | -0.01 11.64% | -0.01 38.77% | -0.01 8.40% | -0.00 39.02% | -0.00 9.15% | -0.00 48.94% | -0.00 13.44% | |
capex to depreciation | -0.05 - | -0.26 388.91% | -1.04 298.00% | -8.07 673.03% | -4.21 47.82% | -3.26 22.50% | -1.86 43.11% | -2.56 37.69% | -1.07 58.05% | -0.88 18.15% | |
capex to operating cash flow | 0.01 - | 0.04 276.86% | 0.13 194.82% | 0.10 24.09% | 0.06 38.62% | 0.09 49.05% | 0.07 14.74% | 0.13 79.11% | 0.03 74.31% | 0.02 28.09% | |
capex to revenue | -0.01 - | -0.03 276.57% | -0.10 214.04% | -0.12 11.84% | -0.06 50.66% | -0.06 6.69% | -0.03 53.54% | -0.04 34.38% | -0.02 34.98% | -0.04 72.52% | |
cash per share | 0.41 - | 0.27 35.85% | 0.23 15.31% | 0.16 27.57% | 0.06 61.92% | 0.08 27.94% | 0.04 55.46% | 0.61 1,637.14% | 0.39 35.96% | 0.31 21.77% | |
days of inventory on hand | 29.74 - | 33.21 11.70% | 26.30 20.81% | 30.05 14.25% | 46.15 53.57% | 45.34 1.76% | 51.67 13.98% | 72.53 40.35% | 82.46 13.70% | 94.02 14.01% | |
days payables outstanding | 47.52 - | 40.97 13.78% | 48.03 17.24% | 58.62 22.04% | 124.41 112.25% | 58.42 53.04% | 52.39 10.32% | 54.02 3.11% | 57.06 5.62% | 102.83 80.20% | |
days sales outstanding | 83.58 - | 84.68 1.31% | 46.30 45.32% | 55.66 20.21% | 73.46 31.98% | 57.59 21.60% | 77.07 33.83% | 73.09 5.17% | 54.37 25.61% | 70.03 28.80% | |
debt to assets | 0.12 - | 0.01 90.46% | 0.01 26.21% | ||||||||
debt to equity | 0.18 - | 0.01 93.44% | 0.01 25.72% | ||||||||
dividend yield | 0.00 - | 0.00 63.92% | 0.00 69.70% | 0.00 42.87% | 0.00 39.64% | 0.00 9.70% | 0.00 27.39% | 0.00 62.72% | |||
earnings yield | -0.04 - | -0.05 1.26% | -0.10 117.18% | -0.18 80.63% | -0.27 51.83% | -0.18 34.63% | -0.09 51.06% | -0.04 55.56% | -0.16 323.47% | -0.41 154.10% | |
enterprise value | 125.47M - | 76.00M 39.43% | 37.72M 50.36% | 28.73M 23.85% | 22.22M 22.65% | 22.16M 0.27% | 36.47M 64.56% | 20.02M 45.10% | -11.35M 156.69% | 14.53M 228.04% | |
enterprise value over ebitda | -32.25 - | -18.75 41.86% | -8.59 54.20% | -4.64 45.95% | -3.32 28.55% | -4.18 26.02% | -10.49 151.01% | -5.84 44.33% | 1.54 126.29% | -0.98 163.78% | |
ev to operating cash flow | -38.87 - | -21.58 44.48% | -9.71 54.99% | -5.03 48.22% | -3.89 22.65% | -4.39 12.82% | -10.02 128.20% | -7.06 29.54% | 1.47 120.86% | -1.19 181.10% | |
ev to sales | 29.74 - | 16.50 44.52% | 7.91 52.06% | 6.03 23.71% | 3.75 37.82% | 3.03 19.24% | 3.77 24.34% | 1.99 47.14% | -1.05 152.79% | 2.05 294.57% | |
free cash flow per share | -0.08 - | -0.07 12.52% | -0.08 18.84% | -0.11 43.08% | -0.11 3.64% | -0.08 25.29% | -0.06 29.33% | -0.03 46.48% | -0.06 81.27% | -0.09 56.27% | |
free cash flow yield | -0.02 - | -0.05 84.41% | -0.09 102.17% | -0.18 97.59% | -0.24 34.91% | -0.20 18.00% | -0.10 48.26% | -0.04 62.53% | -0.18 367.79% | -0.35 93.77% | |
graham net net | 0.37 - | 0.24 34.99% | 0.21 15.65% | 0.15 29.16% | 0.04 73.20% | 0.07 80.24% | 0.02 73.25% | 0.60 3,116.25% | 0.38 36.40% | 0.30 23.12% | |
graham number | 1.33 - | 0.76 43.08% | 0.76 0.25% | 0.70 8.05% | 0.50 28.36% | 0.43 13.50% | 0.30 29.72% | 0.67 120.63% | 0.70 4.45% | 0.95 35.12% | |
income quality | 0.54 - | 0.96 76.61% | 0.82 13.82% | 0.93 12.43% | 0.85 8.03% | 0.98 15.13% | 1.06 7.65% | 0.84 20.72% | 1.06 26.58% | 0.83 21.74% | |
intangibles to total assets | 0.01 - | 0.01 2.38% | 0.01 3.63% | 0.02 125.43% | 0.03 41.68% | 0.02 35.26% | 0.02 7.73% | 0.00 88.36% | 0.00 10.06% | 0.00 10.84% | |
interest coverage | -5.20K - | -1.96K 62.31% | -5.35K 173.14% | 43.50 100.81% | 232.03 433.45% | -62.11 - | |||||
interest debt per share | 0.00 - | 0.00 94.97% | 0.00 57.19% | -0.00 15,362.88% | -0.00 80.05% | 0.01 - | 0.01 49.73% | 0.00 39.40% | |||
inventory turnover | 12.27 - | 10.99 10.47% | 13.88 26.27% | 12.15 12.47% | 7.91 34.88% | 8.05 1.80% | 7.06 12.26% | 5.03 28.75% | 4.43 12.05% | 3.88 12.29% | |
invested capital | 0.18 - | 0.01 93.44% | 0.01 25.72% | ||||||||
market cap | 133.15M - | 81.23M 39.00% | 47.86M 41.07% | 34.66M 27.58% | 24.82M 28.39% | 27.49M 10.74% | 37.86M 37.72% | 83.07M 119.44% | 44.02M 47.02% | 35.53M 19.29% | |
net current asset value | 16.62M - | 14.10M 15.14% | 11.93M 15.43% | 8.62M 27.70% | 3.04M 64.71% | 5.57M 83.14% | 2.53M 54.58% | 64.29M 2,440.18% | 56.17M 12.64% | 49.77M 11.40% | |
net debt to ebitda | 1.97 - | 1.29 34.68% | 2.31 78.99% | 0.96 58.47% | 0.39 59.51% | 1.00 158.86% | 0.40 60.28% | 18.39 4,509.58% | 7.49 59.27% | 1.41 81.11% | |
net income per share | -0.14 - | -0.07 51.97% | -0.09 27.67% | -0.11 30.80% | -0.12 8.45% | -0.07 40.44% | -0.05 33.16% | -0.03 36.51% | -0.05 64.09% | -0.10 104.92% | |
operating cash flow per share | -0.08 - | -0.06 15.17% | -0.07 10.02% | -0.10 47.06% | -0.10 0.26% | -0.08 27.27% | -0.05 28.48% | -0.03 49.27% | -0.05 98.75% | -0.09 57.74% | |
payables turnover | 7.68 - | 8.91 15.99% | 7.60 14.70% | 6.23 18.06% | 2.93 52.88% | 6.25 112.94% | 6.97 11.51% | 6.76 3.02% | 6.40 5.32% | 3.55 44.51% | |
receivables turnover | 4.37 - | 4.31 1.29% | 7.88 82.89% | 6.56 16.81% | 4.97 24.23% | 6.34 27.55% | 4.74 25.28% | 4.99 5.45% | 6.71 34.43% | 5.21 22.36% | |
research and ddevelopement to revenue | 0.16 - | 0.13 15.81% | 0.11 17.04% | 0.20 83.07% | 0.29 45.44% | 0.20 31.63% | 0.12 42.28% | 0.14 22.03% | 0.24 68.50% | 0.37 53.13% | |
return on tangible assets | -0.23 - | -0.16 28.69% | -0.26 62.57% | -0.51 95.04% | -0.92 80.38% | -0.52 43.27% | -0.38 27.09% | -0.05 88.12% | -0.11 145.14% | -0.25 127.46% | |
revenue per share | 0.10 - | 0.08 15.10% | 0.09 3.28% | 0.09 0.18% | 0.11 24.08% | 0.11 1.60% | 0.14 31.25% | 0.10 32.39% | 0.08 21.47% | 0.05 34.25% | |
roe | -0.25 - | -0.18 28.80% | -0.29 62.16% | -0.58 102.35% | -1.33 129.18% | -0.63 52.59% | -0.57 9.55% | -0.05 91.72% | -0.12 146.81% | -0.27 129.99% | |
roic | -0.24 - | -0.17 27.20% | -0.29 66.42% | -0.58 103.50% | -1.33 129.30% | -0.65 51.35% | -0.43 34.19% | -0.05 89.00% | -0.12 148.64% | -0.28 138.19% | |
sales general and administrative to revenue | 0.59 - | 0.52 11.64% | 0.79 52.37% | 0.82 3.65% | 0.70 14.55% | 0.57 18.88% | 0.47 17.22% | 0.47 1.18% | 0.61 31.44% | 1.53 149.38% | |
shareholders equity per share | 0.56 - | 0.38 32.54% | 0.30 21.27% | 0.19 35.36% | 0.09 52.68% | 0.11 25.62% | 0.08 26.10% | 0.65 666.76% | 0.43 33.52% | 0.38 10.90% | |
stock based compensation to revenue | 0.04 - | 0.04 1.08% | 0.06 36.61% | 0.08 28.36% | 0.10 31.16% | 0.06 43.97% | 0.05 10.95% | 0.04 24.91% | 0.10 162.25% | 0.19 87.88% | |
tangible asset value | 23.73M - | 20.58M 13.27% | 16.25M 21.05% | 10.37M 36.17% | 4.83M 53.41% | 7.52M 55.59% | 5.58M 25.71% | 67.28M 1,104.58% | 61.17M 9.08% | 54.56M 10.81% | |
tangible book value per share | 0.56 - | 0.38 32.56% | 0.30 21.24% | 0.19 36.18% | 0.09 53.53% | 0.11 28.01% | 0.08 26.33% | 0.65 684.19% | 0.43 33.50% | 0.38 10.89% | |
working capital | 18.06M - | 15.23M 15.66% | 12.54M 17.71% | 9.19M 26.73% | 3.63M 60.45% | 6.19M 70.49% | 3.93M 36.52% | 65.50M 1,565.84% | 57.06M 12.88% | 50.54M 11.43% |
All numbers in (except ratios and percentages)